Stifel lowered the firm’s price target on Accolade to $8 from $13 and keeps a Buy rating on the shares. Accolade reported an in-line performance for Q1, though its fiscal 2025 revenue guidance was lowered as management prioritizes profitability over growth, the analyst tells investors in a research note. The firm continues to believe Accolade can grow double digits and generate mid-high teens EBITDA margins over time.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
- Options Volatility and Implied Earnings Moves Today, June 27, 2024
- ACCD Upcoming Earnings Report: What to Expect?
- Options Volatility and Implied Earnings Moves This Week, June 24 – June 27, 2024
- Accolade to Announce Fiscal First Quarter 2025 Financial Results
- Accolade price target lowered to $13 from $17 at Guggenheim